<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Intractable Rare Dis Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Intractable Rare Dis Res</journal-id>
<journal-id journal-id-type="publisher-id">irdr</journal-id>
<journal-id journal-id-type="hwp">irdr</journal-id>
<journal-title-group>
<journal-title>Intractable &amp; Rare Diseases Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">2186-3644</issn>
<issn pub-type="epub">2186-361X</issn>
<publisher>
<publisher-name>International Research and Cooperation Association for Bio &amp; Socio-Sciences Advancement</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27672544</article-id>
<article-id pub-id-type="pmc">4995423</article-id>
<article-id pub-id-type="doi">10.5582/irdr.2016.01046</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Alcohol use dependence in fragile X syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Salcedo-Arellano</surname>
<given-names>Mar√≠a J</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="a2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="a3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lozano</surname>
<given-names>Reymundo</given-names>
</name>
<xref ref-type="aff" rid="a4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tassone</surname>
<given-names>Flora</given-names>
</name>
<xref ref-type="aff" rid="a3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="a5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagerman</surname>
<given-names>Randi J</given-names>
</name>
<xref ref-type="aff" rid="a3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="a6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saldarriaga</surname>
<given-names>Wilmar</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="a2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="a7">
<sup>7</sup>
</xref>
</contrib>
<aff id="a1"><label>1</label> School of Medicine, Universidad del Valle, Cali, Colombia</aff>
<aff id="a2"><label>2</label> Research Group in Congenital &amp; Perinatal Malformations, Dysmorphology and Clinical Genetics (MACOS), Universidad del Valle, Cali, Colombia</aff>
<aff id="a3"><label>3</label> Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California, Davis Medical Center, Sacramento, CA, USA</aff>
<aff id="a4"><label>4</label> Seaver Autism Center. Departments of Genomic Sciences, Psychiatry and Pediatrics. Icahn School of Medicine, Mount Sinai Hospital, New York, NY, USA</aff>
<aff id="a5"><label>5</label> Department of Biochemistry and Molecular Medicine, University of California, Davis, USA</aff>
<aff id="a6"><label>6</label> Department of Pediatrics, University of California, Davis Medical Center, Sacramento, CA, USA</aff>
<aff id="a7"><label>7</label> Departments of Morphology and Obstetrics &amp; Gynecology, Universidad del Valle, Hospital Universitario Del Valle, Cali, Colombia</aff>
</contrib-group>
<author-notes>
<corresp id="c1"><label>*</label><italic>Address correspondence to:</italic> Dr. Maria J Salcedo-Arellano, School of Medicine, Universidad del Valle, Cali, Colombia. E-mail: <email>jimena.salcedo@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>8</month>
<year>2016</year>
</pub-date>
<volume>5</volume>
<issue>3</issue>
<fpage>207</fpage>
<lpage>213</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>6</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>2016, International Research and Cooperation Association for Bio &amp; Socio-Sciences Advancement</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<title>Summary</title>
<p>Alcohol use disorders (AUDs) have been reported in a limited number of individuals with cognitive impairment but rarely in those with fragile X syndrome (FXS). However, in Colombia, culturally, alcohol consumption is very common. Here, we report eight cases of patients with FXS who have frequent alcohol consumption in Ricaurte, Colombia. Some of these patients have also used tobacco and illegal substances, including cocaine, which use has not been previously reported in those with FXS. Alcohol and substance use dependence is associated with exacerbation of their behavioral problems, such as increased impulsivity and aggression, as well as of medical problems such as an increased frequency of seizures.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Alcohol use disorders</kwd>
<kwd>fragile X syndrome</kwd>
</kwd-group>
<counts>
<fig-count count="8"></fig-count>
<table-count count="2"></table-count>
<ref-count count="36"></ref-count>
<page-count count="7"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>